NCT06549608View on ClinicalTrials.gov

A Retrospective Cohort Study of Mavacamten Patient Support Program in Canada

Active, not recruitingOBSERVATIONAL
Enrollment

685

Participants

Timeline

Start Date

April 20, 2024

Primary Completion Date

May 6, 2024

Study Completion Date

April 18, 2025

Conditions
Hypertrophic Cardiomyopathy
Interventions
DRUG

Mavacamten

As per product label

Trial Locations (1)

Unknown

St. Paul's Hospital, Vancouver

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY